Diopsys became a wholly owned subsidiary of LumiThera, Inc.
Diopsys is now a wholly owned subsidiary of LumiThera.
The number of Americans suffering from diabetes-related blindness is expected to nearly double by 2050 but we have the means to help stop this silent killer...
The transaction is expected to close in the next few months.
Get the most important news and business ideas for eyecare professionals every weekday from INVISION.